Karriereverlauf von Scott Lauder
Ehemalige bekannte Positionen von Scott Lauder
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GEMI THER | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2016 | 17.09.2021 |
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.07.2013 | 01.10.2016 |
Ausbildung von Scott Lauder
| University of Manitoba | Undergraduate Degree |
| Northwestern University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Kanada | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Scott Lauder
- Erfahrung